Claude 4.6 Jailbroken: Anthropic's Safety Charade Crumbles in 27 Days of Silence
Anthropic's Claude 4.6 models just got embarrassing. A researcher jailbroke all tiers, extracted production secrets, and got zero response after 27 days of pings.
Anthropic's Claude 4.6 models just got embarrassing. A researcher jailbroke all tiers, extracted production secrets, and got zero response after 27 days of pings.
Imagine AI bots wheeling and dealing faster than any human trader. Visa's latest report says businesses are primed for it – as long as they hold the override button.
Picture this: Windows auto-tile like puzzle pieces, animations glide smooth as butter, and your Linux desktop hums with efficiency. Hyprland isn't just a window manager; it's your new productivity superpower.
What if installing Arch Linux felt less like a ritual sacrifice and more like gliding into the future? Arch Installer 4.0 just made that real, swapping clunky curses for a vibrant Textual overhaul.
Picture firing up your terminal for the latest AI coding tool — only to accidentally download a company's entire secret playbook. That's what happened when Anthropic's negligence gifted the world their crown jewels.
Your app's dashboard mounts five components. Token's expired. Boom—five refresh requests collide. Here's the dead-simple fix pros use.
Safe, the non-custodial wallet giant, just dropped Safenet — a network that weaponizes SAFE tokens against phishing and hacks. It's bold, but in a market drowning in exploits, will it deliver?
Bitcoin's flirting with $66K on Good Friday, but packed short positions scream upside pain. Analysts smell blood in the water for the bears.
$250 million in Bitcoin, gone in a quarter. Riot Platforms is betting big on AI, but after two straight quarters of sales, who's really winning here—the miners or the HODLers they mocked?
Crawl4AI's default Markdown output is solid, but rs-trafilatura? It classifies pages, scores quality, and extracts like a pro—lifting benchmarks from 0.893 to 0.910 F1. Here's how to plug it in.
Picture this: your AI buddy suddenly knows advanced prompt engineering without you typing a word. spm, the new package manager for AI skills, promises to end the chaos of scattered prompts forever.
One dev just deployed a full-stack AI app detecting Alzheimer's via EEG—for exactly zero bucks. Here's the AWS-Cloudflare blueprint that makes it possible, pitfalls included.
For two decades, fintechs thrived by outsourcing banking to partners. Now Affirm, Upstart, and Payoneer are applying for their own charters. The shift signals a fundamental reshuffling of fintech economics—and a reckoning with who controls the customer relationship.
Snap a photo of a leaf. Watch as AI spits out the plant's scientific name, medicinal powers, and if it's rotting from disease. One dev just built the tool traditional healers have needed for centuries.
A developer built a free VS Code extension after nearly pushing a live Stripe key to GitHub. EnvGuard now catches 30+ types of secrets before they escape into the wild.
Europe's crypto regulators are locked in a power struggle that has nothing to do with whether to regulate—and everything to do with who gets to do it. Malta is pushing back hard against ESMA's bid for centralized control, and the outcome will reshape how the entire bloc supervises digital assets.
Eve Halimi and Anam Lakhani walked away from Wall Street analyst roles because they saw something the industry couldn't: a massive, ignored market of young women who wanted to invest but felt locked out. Their startup Alinea Invest isn't just filling a gap—it's exposing how broken traditional wealth management really is.
A single screen rotation nuked my form data — 45 minutes gone. That's Android's welcome mat for newbies, and it's brutal.
Your users hate passwords. You hate managing them. Passkeys and WebAuthn finally offer escape — if you dodge the dev traps that keep most apps chained to 2005 tech.
You've been patching broken E2E tests for months. Your team's confidence is shot. The problem isn't the tests themselves—it's that you're treating symptoms instead of disease.